BiotechTube
Home/Pipeline/Turq-102

Turq-102

Colon Cancer

PreclinicalActive

Key Facts

Indication
Colon Cancer
Phase
Preclinical
Status
Active
Company
Turquoise Biotechnologies

About Turquoise Biotechnologies

Exosome‑engineered delivery platform for targeted therapeutics across oncology and autoimmune diseases.

View full company profile

Therapeutic Areas

OncologyImmunologyGastroenterologyNeurologyCardiology

Other Colon Cancer Drugs

DrugCompanyPhase
15dPMJ2Claradele PharmaceuticalsPre-clinical
PRDM1 TargetARIZ Precision MedicinePreclinical